In his latest blog post, Matthew Gould, CEO of NHSX, has reiterated the potential AI has to reduce the burden on the NHS by improving patient outcomes and increasing productivity. However, he said there are gaps in the rules that govern the use of AI and a lack of clarity on both standards and roles.
These gaps mean there is a risk of using AI that is unsafe and that NHS organisations will delay employing AI until all the regulatory gaps have been filled. Gould says, “The benefits will be huge if we can find the sweet spot” that allows trust to be maintained whilst creating the freedom for innovation but warns that we are not in that position yet.
At the end of January, the CEOs and heads of 12 regulators and associated organisations met to work through these issues and discuss what was required to ensure innovation-friendly processes and regulations are put in place.
They agreed there needs to be a clarity of role for these organisations, including the MHRA being responsible for regulating the safety of AI systems; the Health Research Agency (HRA) for overseeing the research to generate evidence; NICE for assessing whether new AI solutions should be deployed; and the CQC to ensure providers are following best practice.
Source: Techradar, 13 February 2020
Recommended Comments
Create an account or sign in to comment